The 'boon and bane' of antipsychotic-induced metabolic syndrome

Acta Psychiatr Scand. 2009 Dec;120(6):500-1; author reply 501. doi: 10.1111/j.1600-0447.2009.01415.x. Epub 2009 May 29.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antipsychotic Agents / adverse effects*
  • Antipsychotic Agents / therapeutic use
  • Apoptosis / drug effects
  • Central Nervous System / drug effects
  • Central Nervous System / metabolism
  • Humans
  • Leptin / metabolism*
  • Metabolic Syndrome / chemically induced*
  • Metabolic Syndrome / metabolism
  • Neuroprotective Agents / metabolism
  • Neuroprotective Agents / pharmacology
  • Psychotic Disorders / drug therapy*
  • Psychotic Disorders / metabolism
  • Psychotic Disorders / physiopathology
  • Schizophrenia / drug therapy
  • Weight Gain / drug effects*

Substances

  • Antipsychotic Agents
  • Leptin
  • Neuroprotective Agents